June 2, 2008
Childhood cancer: In a May 26 article on survivors of childhood cancer, Dr. Jacqueline Casillas was referred to as director of the UCLA-Livestrong Survivorship Center of Excellence. She is associate director; the director is Dr. Patricia Ganz. The article said the UCLA-Livestrong center was in the Mattel Children's Hospital. It is part of UCLA's Jonsson Comprehensive Cancer Center. The same article said that a study of childhood cancer survivors that found a five to 10 times greater risk of heart disease in early adulthood (compared with healthy siblings)
June 2, 2008 |
A simple blood test may be able to detect lung cancer in its early stages, which would represent a promising strategy to improve survival rates, researchers said. The two-year survival rate averages only about 15%, mainly because the disease, which kills 1.3 million people globally a year, is often diagnosed in advanced stages. Preliminary findings of a study presented in Chicago at the annual meeting of the American Society of Clinical Oncology suggest that a specific genetic profile for lung cancer is present in the blood and can be detected with 88% accuracy.
May 17, 2008 |
A growing number of women with early-stage breast cancer seem to be choosing to have the whole breast removed instead of just the cancerous lump, a Mayo Clinic study of about 5,500 women found. Mastectomies were standard treatment until 1990, when studies showed that women whose cancers were small and confined to the breast did just as well if they had less radical surgery followed by radiation. Researchers are not sure what is responsible for the new trend, but speculate that newer tests like MRI scans are finding more cancers, or flagging so many suspicious spots that women want the breast removed for peace of mind.
December 29, 2011 |
Doctors and patients eager for better ways to treat advanced ovarian cancer were encouraged by two new studies showing that adding Avastin to traditional chemotherapy drugs allowed women with the disease to live a few months before their cancer returned or worsened. The two large , international studies credited Avastin with providing an additional 3.8 months and 3.6 months of “progression-free survival.” (The reports in Thursday's edition of the New England Journal of Medicine weren't able to say whether the women who took Avastin lived longer overall.)
January 11, 2011 |
Ryan Lamantia and Walter Wetzel were two very ill young boys -- one with brain cancer, the other with leukemia. One made it, one didn't. And that's where this story starts. The boys met in a hospital during their respective treatments. This Chicago Tribune story tells what happened: "He inspired me to survive my cancer," Walter, now 17, in remission and quite the football player and snowboarder, says in the story. "Seeing him happy all the time made me happy. How could I be upset if he had it so much worse than me?"
February 7, 2011 |
Breast cancer survival rates have improved in recent years, and women have more treatment choices, including -- in cases of early-stage cancer -- the opportunity to forgo chemotherapy. A new study shows, however, that women who undergo chemotherapy experience more symptoms in the year after surgery. Researchers led by Dr. Patricia A. Ganz of UCLA, found that women who have chemotherapy can have symptoms that persist for even a year. These include vaginal symptoms, musculoskeletal pain and weight problems.